Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 62 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II/III Chemotherapy with Streptozotocin plus 5-FU or ADR vs Chlorozotocin for Metastatic, Unresectable, or Recurrent Primary Islet Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-3278

Last Modified: 8/1/2005


2.		Phase II/III Chemotherapy with SZC/5-FU vs ADR/5-FU for Unresectable Carcinoid Tumors, with DTIC for Failures (Summary Last Modified 07/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				EST-1281

Last Modified: 9/25/2007


3.		Phase III Chemotherapy with FAM-S (5-FU/ADR/MITO/SZC) vs a Phase II Drug for Locally Inoperable or Metastatic Pancreatic Adenocarcinoma, a Master Protocol

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 70				NCI				SWOG-8040

Last Modified: 5/9/2007


4.		Phase II - III Study of Chemotherapy with MeCCNU, SZC/CTX and SZC/5-FU for Advanced Unresectable Pancreatic Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-2272 MAYO-706013


5.		Master Protocol for Phase II-III Chemotherapy for Pancreatic Carcinoma --- PALA vs SAM (STZ/ADR/MeCCNU)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified				NCI				EST-2279

Last Modified: 5/22/2007


6.		Phase II and III Chemotherapy with Streptozotocin Alone and Combined with 5-FU or CTX for Pancreatic Islet Cell and Carcinoid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-3272 MAYO-706011


7.		Chemotherapy with 5-FU, Streptozotocin, Spironolactone and L-PAM for Advanced Nonmeasurable Pancreatic Carcinoma (Summary last modified 06/97 ko)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-5274 MAYO-706031


8.		Phase III Chemotherapy with MOF (MeCCNU/VCR/5-FU) vs MOF-STREP (MOF plus SZC) for Advanced, Measurable Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NCI-D79-024-235 MSKCC-7814

Last Modified: 7/1/1997


9.		Phase III Chemotherapy with Mitomycin-C/5-FU with or without Streptozotocin for Pancreatic Adenocarcinoma (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7738


10.		Phase III CVPP (CCNU/VBL/PCB/PRED) Alone or in Combination with Involved or Extended Field Radiotherapy for Stage I/II Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				over 16				NCI				CLB-7751

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute